Transcode Therapeutics Correlations

RNAZ Stock  USD 7.53  0.07  0.92%   
The current 90-days correlation between Transcode Therapeutics and In8bio Inc is 0.03 (i.e., Significant diversification). The correlation of Transcode Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Transcode Therapeutics Correlation With Market

Significant diversification

The correlation between Transcode Therapeutics and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Transcode Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Transcode Stock please use our How to Invest in Transcode Therapeutics guide.

Moving together with Transcode Stock

  0.74HPQ HP IncPairCorr
  0.71MSFT MicrosoftPairCorr

Moving against Transcode Stock

  0.79ACW Actinogen MedicalPairCorr
  0.77MTC MMTEC Inc Tech BoostPairCorr
  0.7AAPL Apple IncPairCorr
  0.67AMGN Amgen IncPairCorr
  0.62MRK Merck Company Aggressive PushPairCorr
  0.59NHIC NewHold Investment CorpPairCorr
  0.52CIZ Cizzle BiotechnologyPairCorr
  0.48JBHT JB Hunt TransportPairCorr
  0.43MCD McDonaldsPairCorr
  0.38ALRS Alerus Financial CorpPairCorr
  0.33GILD Gilead SciencesPairCorr
  0.78DD Dupont De NemoursPairCorr
  0.66CSCO Cisco Systems Sell-off TrendPairCorr
  0.58AXP American ExpressPairCorr
  0.54MMM 3M CompanyPairCorr
  0.52KO Coca ColaPairCorr
  0.51JPM JPMorgan ChasePairCorr
  0.5JNJ Johnson JohnsonPairCorr
  0.45AA Alcoa Corp Sell-off TrendPairCorr
  0.37WMT Walmart Common StockPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HCWBPHIO
PHIOLYRA
HCWBLYRA
KPRXLYRA
KPRXPHIO
APREHCWB
  

High negative correlations

APREGLTO
PHIOGLTO
HCWBGLTO
GLTOLYRA
KPRXGLTO
GLTOINAB

Risk-Adjusted Indicators

There is a big difference between Transcode Stock performing well and Transcode Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Transcode Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
INAB  3.90 (0.38) 0.00 (0.09) 0.00 
 9.57 
 27.61 
LYRA  3.99 (0.81) 0.00 (0.44) 0.00 
 7.51 
 30.53 
APVO  4.16 (0.70) 0.00 (0.24) 0.00 
 8.54 
 36.30 
GLTO  22.03  9.23  0.90  1.86  8.35 
 38.50 
 423.59 
PHIO  3.01 (1.04) 0.00 (0.31) 0.00 
 5.08 
 21.95 
HCWB  4.46 (1.42) 0.00 (0.59) 0.00 
 8.72 
 42.33 
KPRX  2.81 (0.25) 0.00 (1.72) 0.00 
 5.70 
 21.80 
APRE  2.98 (0.72) 0.00 (0.28) 0.00 
 4.40 
 17.87 
BOLT  3.37  0.14  0.03  0.19  4.22 
 8.13 
 27.55 
ACXP  6.03  0.28  0.05  0.33  5.18 
 10.99 
 99.56 

Transcode Therapeutics Corporate Management

RN MBASenior OperationsProfile
Daniel MDChief OfficerProfile
Anna MooreScientific CoFounderProfile
Calais PharmExecutive BoardProfile
Robert DudleyCEO, CoFounderProfile